Radiotherapy is one of the mainstays of anticancer treatment, but the relationship between
the radiosensitivity of cancer cells and their genomic characteristics is still not well defined …

This paper explores historical and current roles of pharmaceutical industry sponsorship of
clinical trials testing radiation therapy combinations with molecularly targeted agents and …

The recently developed ability to interrogate genome-wide data arrays has provided
invaluable insights into the molecular pathogenesis of lung cancer. These data have also …

Background: The efficacy of radiotherapy (RT) for cancer treatment is limited by normal
tissue toxicity and by the intrinsic or acquired radioresistance of many tumours. Therefore …

Cancer Drug Discovery and Development, the Springer series headed by Beverly A.
Teicher, is the definitive book series in cancer research and oncology. Volumes cover the …

This textbook on Molecular Radio-Oncology is targeting physicians and preclinical
researchers with interest in translational radiation oncology. The first part of the book takes …

Radiotherapy continues to remain a major treatment modality for solid tumors. However,
advances in fundamental radiobiology suggest that improvements in tumor control can be …

The reach of personalized medicine in radiation oncology has expanded greatly over the
past few decades as technical precision has improved the delivery of radiation to each …

Radiotherapy plays an essential role in the treatment of more than half of all patients with
cancer. In recent decades, advances in devices that deliver radiation and the development …

Radiation therapy is a major treatment modality used in> 60% of cancer patients as
definitive local treatment for inoperable locoregionally confined tumors and as palliative …